24 May,2021 07:29 PM IST | New Delhi | ANI
Representational Image | File Pic
To bring Pfizer-BioNTech Covid-19 vaccine for use in India, discussions are underway between the Government of India (GOI) and Pfizer Inc. In a statement on Monday, Pfizer spokesperson said: "Pfizer's discussions with the GOI are ongoing and we are hopeful to bring the Pfizer-BioNTech Covid-19 vaccine for use in the country. We are unable to divulge further details at this moment."
On state procurement tenders, the US vaccine maker said it will supply vaccines only to central governments. "Pfizer will supply Covid-19 vaccine only to central governments and supra-national organisations for deployment in national immunization programs. Allocation of doses and implementation plan within a country is a decision for local governments based on relevant health authority guidance," it said.
Also Read: RDIF, Panacea Biotec to start Sputnik V production in India
Pfizer said that the development, manufacturing, distribution and storage of complex innovative products, including the mRNA technology, requires globally-optimized supply chains. "Since the beginning of this pandemic, Pfizer's priority has been to ensure rapid manufacturing and deployment of the Covid-19 vaccine to cater to the current emergency response scenario.
ALSO READ
7.5 mn doses of Moderna Covid-19 vaccine offered to India through COVAX: WHO
Pfizer, J&J yet to apply for license of Covid-19 vaccines in India: Sources
Mixing Covid doses may help boost immune response: Study
Serum Institute asks govt to speak with EU for inclusion
Delta variant now reported in 85 countries, expected to become dominant lineage
We have a robust supply chain currently in place with established capabilities - one each in the US and one in Europe - that can quickly manufacture and deploy the vaccine for use across the world," the spokesperson said. Pfizer and BioNTech have set a target to deliver over 2.5 billion vaccine doses in 2021. This includes expanding the manufacturing capabilities and increasing the supplier base for key materials to the supply chain, said the company official.
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever